| # | Drug | Count |
|---|---|---|
| 0 | IBRUTINIB | 911 |
| 1 | VENETOCLAX | 778 |
| 2 | RITUXIMAB | 685 |
| 3 | CYCLOPHOSPHAMIDE | 283 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 283 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 283 |
| 6 | ALLOPURINOL | 274 |
| 7 | PREDNISONE | 270 |
| 8 | SIMVASTATIN | 254 |
| 9 | FLUDARABINE PHOSPHATE | 244 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PIRTOBRUTINIB | 41 | 0.0418 |
| 1 | CHLORAMBUCIL | 85 | 0.0216 |
| 2 | PENTOSTATIN | 20 | 0.0190 |
| 3 | IDELALISIB | 114 | 0.0162 |
| 4 | BENDAMUSTINE HYDROCHLORIDE | 108 | 0.0127 |
| 5 | VENETOCLAX | 778 | 0.0124 |
| 6 | IBRUTINIB | 911 | 0.0112 |
| 7 | BENDAMUSTINE HCL | 151 | 0.0096 |
| 8 | ZANUBRUTINIB | 34 | 0.0075 |
| 9 | OBINUTUZUMAB | 111 | 0.0066 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 1111 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 807 |
| 2 | BCL-2 Inhibitor [EPC] | 778 |
| 3 | Corticosteroid [EPC] | 512 |
| 4 | Alkylating Drug [EPC] | 366 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 312 |
| 6 | Xanthine Oxidase Inhibitor [EPC] | 287 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 284 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 254 |
| 9 | Thalidomide Analog [EPC] | 224 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 15 | 0.0218 |
| 1 | BCL-2 Inhibitor [EPC] | 778 | 0.0124 |
| 2 | Thrombopoietin Receptor Agonist [EPC] | 77 | 0.0051 |
| 3 | Human Immunoglobulin G [EPC] | 103 | 0.0049 |
| 4 | Provitamin D2 Compound [EPC] | 121 | 0.0041 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 64 | 0.0033 |
| 6 | Hematopoietic Stem Cell Mobilizer [EPC] | 4 | 0.0027 |
| 7 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 807 | 0.0025 |
| 9 | Kinase Inhibitor [EPC] | 1111 | 0.0020 |